IMARC Group’s report titled “Dialysis Market Report by Type (Hemodialysis, Peritoneal Dialysis), Product and Services (Services, Equipment, Consumables, Dialysis Drugs), End User (In-center Dialysis, Home Dialysis), and Region 2023-2028“. The global dialysis market size reached US$ 110.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 148.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/dialysis-market/requestsample

Factors Affecting the Growth of the Dialysis Industry:

  • Rising Prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD):

The increasing incidence of chronic kidney diseases and end-stage renal disease

(ESRD) is a primary factor impelling the dialysis market in Japan. Chronic kidney diseases, often resulting from diabetes, hypertension, and other chronic conditions, can lead to kidney failure, necessitating dialysis treatment. The World Health Organization (WHO) and other health bodies are also reporting a steady rise in these conditions, thereby propelling the demand for dialysis services and equipment. Public health campaigns and educational programs emphasizing early detection and management of kidney diseases also play a role in increasing the demand for dialysis services as they lead to higher diagnosis rates.

  • Technological Advancements in Dialysis Procedures:

Technological advancements in dialysis to treatment efficacy and patient comfort are contributing to the market growth. Developments in dialysis technology, such as wearable dialysis devices and improvements in peritoneal dialysis, are transforming patient experiences. These technologies not only make dialysis more efficient but also more accessible, especially for patients in remote areas or those who prefer home-based treatment. The integration of digital technology, such as telemedicine and electronic health records (EHRs), further facilitates patient monitoring and personalized treatment plans. This continuous innovation attracts investments and research, further driving the demand for dialysis.

  • Government Initiatives and Reimbursement Policies:

The governing agencies are recognizing the importance of providing accessible renal care and implementing policies that support dialysis treatment. These policies often include reimbursement schemes that cover a significant portion of the treatment costs, making dialysis more affordable for patients. Additionally, regulatory bodies are investing in healthcare infrastructure that supports the delivery of dialysis services, such as establishing specialized renal care centers and facilitating training for healthcare professionals in nephrology. They are also constructing hospitals and nursing homes to provide quality healthcare services to people.

Leading Companies Operating in the Global Dialysis Industry:

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dikinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • JMS Co. Ltd.
  • Medtronic plc
  • Nikkiso Co. Ltd.
  • NIPRO Corporation
  • Satellite Healthcare Inc.
  • Toray Industries Inc.

Dialysis Market Report Segmentation:

By Type:

  • Hemodialysis
    • Conventional Hemodialysis
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

Based on the type, the market has been segmented into hemodialysis (HD) (conventional hemodialysis, short delete hemodialysis, and nocturnal hemodialysis) and peritoneal dialysis (PD) (continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)).

By Product and Services:

  • Services
  • Equipment
    • Dialysis Machines
    • Water Treatment Systems
    • Others
  • Consumables
    • Dialyzers
    • Catheters
    • Others
  • Dialysis Drugs

On the basis of the product and services, the market has been segregated into equipment (dialysis machines, water treatment systems, and others), consumables (dialysis, catheters, and others), dialysis drugs, and services.

By End User:

  • In-center Dialysis
  • Home Dialysis

Based on end user, the market has been bifurcated into in-center dialysis and home dialysis.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Region-wise, the market has been divided into Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region. 

Dialysis Market Trends:

Japan is renowned for its advanced healthcare system, which includes state-of-the-art medical technologies and highly skilled healthcare professionals. This infrastructure supports the delivery of high-quality dialysis treatment, both in hospitals and through home dialysis programs. The rising focus on healthcare innovation and quality is supporting the market growth. Moreover, the increasing occurrence of various lifestyle-related diseases like diabetes and hypertension, which are leading causes of chronic kidney diseases, is strengthening the market growth. There is a rising awareness of kidney health and the importance of early intervention in Japan. Public health initiatives and educational programs aimed at promoting kidney health and preventing kidney diseases are contributing to earlier diagnosis and treatment. This heightened awareness is leading to increased demand for dialysis services as more individuals seek treatment.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163